Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Columnists


About GlobeNewswire

GlobeNewswire
GlobeNewswire, GlobeNewswire and NASDAQ OMX
We specialize in the delivery of corporate press releases, financial disclosures, and multimedia content to the media, investment community ...


GlobeNewswire's Most Recent Articles

Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily...

GlobeNewswire | 6 hours ago

Prospera Energy Inc. Announces 2023 Financial Results

GlobeNewswire | 6 hours ago

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab...

GlobeNewswire | 9 hours ago

SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to...

GlobeNewswire | 9 hours ago

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent...

GlobeNewswire | 9 hours ago

ClearPoint Neuro Announces Full Market Release of SmartFrame OR(TM) and ClearPoint PRISM® 3T...

GlobeNewswire | 10 hours ago

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as...

GlobeNewswire | 10 hours ago

Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting

GlobeNewswire | 10 hours ago

Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting

GlobeNewswire | 11 hours ago

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and...

GlobeNewswire | 11 hours ago
1 2 3 4 5 6 7 8 9 10 ... Next